Atlas Trials

Relapsing Multiple Sclerosis (RMS)

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsing Multiple Sclerosis (RMS)

RecordFirmDate
A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab (NCT04878211)Novartis Pharmaceuticals2021-06-10
Study of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) Patients (NCT04667949)Novartis Pharmaceuticals2021-02-20
An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis (NCT04130997)TG Therapeutics, Inc.2019-11-18
Effects of Cladribine Tablets on the PK of Microgynon® (NCT03745144)Merck KGaA, Darmstadt, Germany2019-01-17
Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) ( ULTIMATE 1 ) (NCT03277261)TG Therapeutics, Inc.2017-09-19
Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) (NCT03277248)TG Therapeutics, Inc.2017-08-25
Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS) (NCT02921035)Merck KGaA, Darmstadt, Germany2016-06-30

Track Relapsing Multiple Sclerosis (RMS) automatically

Every clearance here is in the API, with alerts when new ones post.